Venturi Wealth Management LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 6,102 shares of the financial services provider’s stock, valued at approximately $1,058,000.
Other hedge funds have also recently bought and sold shares of the company. State Street Corp acquired a new position in Marsh & McLennan Companies in the 4th quarter valued at about $4,057,682,000. Capital International Investors acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $3,482,557,000. Capital World Investors purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter valued at approximately $3,140,284,000. Wellington Management Group LLP purchased a new stake in Marsh & McLennan Companies during the 4th quarter worth approximately $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in Marsh & McLennan Companies during the 4th quarter worth approximately $1,710,101,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies stock opened at $168.83 on Friday. The firm has a market capitalization of $81.56 billion, a price-to-earnings ratio of 21.10, a price-to-earnings-growth ratio of 2.46 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $219.71.
Wall Street Analyst Weigh In
Several equities analysts have commented on MRSH shares. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, May 6th. Barclays decreased their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Morgan Stanley cut their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. Keefe, Bruyette & Woods increased their price target on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. Finally, Mizuho lowered their price objective on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies has an average rating of “Hold” and an average target price of $200.19.
Read Our Latest Research Report on Marsh & McLennan Companies
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by company insiders.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
